Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
The UK Myeloma Society Autumn Day & Scientific Forum 2025 will explore the integration of immunotherapies in myeloma care, alongside updates on AL amyloidosis. This hybrid event brings together experts from across the UK to share clinical insights, emerging data, and practical approaches to care.
Co-chaired by Dr Charlotte Pawlyn (The Institute of Cancer Research) and Dr Karthik Ramasamy (Oxford University Hospitals), the forum will cover topics including relapse management, treatment sequencing, toxicity challenges, and service developments.
Programme highlights include
CAR-T and bispecifics in relapsed/refractory myeloma.
Managing toxicity in novel immunotherapies.
Early relapse strategies and sequencing challenges.
National amyloidosis service update.
Panel Q&A on real-world challenges in myeloma care.
The Michael Morley Lecture Delivered by Dr Paola Neri (University of Calgary): “Opportunities and challenges with immunotherapy in myeloma”.
Who should attend
Consultant haematologists, specialist nurses, pharmacists, registrars, and other HCPs involved in the care of people with myeloma or AL amyloidosis.
–
